|
David Allen
Executive Chairman, Stem Cell Therapeutics Corp.
|
|
|
Paul Dick
President, Paul Dick & Associates
|
|
|
Denis Ferkany
Director Corporate Strategy, International Consortium on Anti-Virals
|
|
|
Scott Gillis
Director of Business Development & Commercialization, Thunder Bay Regional Research Institute
|
|
|
Pat Van Gelder
Head of Sales & Marketing, Sanofi Pasteur Limited
|
|
|
Dr. Raphael (Rafi) Hofstein
President & CEO, MaRS Innovation
|
|
|
Jason Locklin
Director, Government, Public & Community Relations, Bombardier Aerospace
|
|
|
Lorne Meikle
President & CEO, Management Dynamics Ltd.
|
|
|
Graeme McRae
Chairman, President & CEO, Bioniche Life Sciences Inc.
|
|
|
Allan O'Dette
President & CEO, Ontario Chamber of Commerce
|
|
|
Jayson Parker
Academic Director, Biotech Bridging Program, University of Toronto
|
|
|
Dale E. Patterson
Vice President, External Relations, Genome Canada
|
|
|
Dr. Gregory Penner
President & CEO, NeoVentures Biotechnology Inc.
|
|
|
Benjamin Rovinski
Managing Director, Lumira Capital
|
|
|
Mark Smithyes
Manager of Health Policy, Novartis
|
|
|
Alison Symington
VP, Corporate Development and Communications, Ontario Genomics Institute
|
|
|
Jean Szkotnicki
President, Canadian Animal Health Institute
|
|
|
Bernard West
President, Ontario BioAuto Council
|
|
|
Russell Williams
President, Rx & D
|
|
